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IDENTIFICATION AND CHARACTERIZATION OF HUMAN MONOCLONAL ANTIBODIES 
FOR IMMUNOPROPHYLAXIS AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI 
 
Serena Giuntini, Matteo Stoppato, Maja Sedic, Monir Ejemel, Danielle Wisheart, Mark S. 
Klempner, Yang Wang 
MassBiologics of UMMS, Boston, MA 
 
Background.  Enterotoxigenic Escherichia coli (ETEC) infections are the major cause of 
diarrheal morbidity among children living in developing countries. ETEC mediates small 
intestine adherence through bacterial adhesion followed by production of enterotoxins that 
induce diarrhea. Currently there is no vaccine available for ETEC. One of the most predominant 
adhesin of pathogenic ETEC strains is colonization factor antigen I (CFA/I). The CFA/I adhesion 
tip, CfaE, is required for ETEC binding to human intestinal cells and colonization. Human 
antibodies against CfaE have potential to block colonization of ETEC and serve as a potent 
immunoprophylactic against ETEC-related diarrhea.  
 
Methods. A panel of human IgG1 monoclonal antibodies (HuMAbs) were generated against 
CfaE. The antibodies were tested in vitro for blockage of bacterial adhesion to intestinal cells 
and in vivo for inhibition of bacterial colonization in the ileum. Antibody epitope analysis were 
performed using BioLuminate software (Schrodinger, Inc.), followed by mutagenesis of the 
predicted residues located in the antibody/CfaE interface and in-vitro binding assays.  
 
Results. The lead IgG1 anti-CfaE HuMAbs blocked 50% of adhesion of ETEC bacterial cells to 
human intestinal cells at concentrations ranging from 0.3 to 1.3 ug/ml. In vivo studies revealed 2 
to 4 log decrease in colony forming units in the small intestine when the bacteria were pre-
incubated with anti-CfaE MAbs as compared to an irrelevant isotype control. In silico epitope 
analysis revealed critical residues involved in the MAbs interaction with CfaE. Two of the leads 
HuMabs recognize epitopes sequence conserved across other 6 major adhesins. 
 
Conclusions. We have identified a panel of fully human IgG1 monoclonal antibodies against 
CfaE protein of ETEC. These antibodies are capable of blocking in vitro and in vivo ETEC 
adhesion to intestinal cells at low concentrations. Two lead antibodies recognizing sequence 
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